GH1 and serum lipopolysaccharide activity: As research advanced, scholars began to investigate the pathogenesis of sarcopenia, including hepatic–muscle axis mediators (e.g., hyperammonemia, low growth hormone levels, endotoxemia, etc.)[49–51], as well as the role of gut microbiota [52].